Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study

Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study

Compare heart failure (HF) costs of Furoscix use at home compared with inpatient intravenous (IV) diuresis. Prospective, case control study of chronic HF patients presenting to emergency department (ED) with worsening congestion discharged to receive Furoscix 80 mg/10 ml 5-h subcutaneous infusion fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future cardiology 2023-06, Vol.19 (8), p.385-396
Hauptverfasser: Bensimhon, Daniel, Weintraub, William S, Peacock, William Frank, Alexy, Tamas, McLean, Dalton, Haas, Donald, Deering, Kathleen L, Millar, Stefanie J, Goodwin, Matthew M, Mohr, John F
Format: Artikel
Sprache:eng
Schlagworte:
congestion
diuretics
emergency department
Furosemide
heart failure
subcutaneous
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compare heart failure (HF) costs of Furoscix use at home compared with inpatient intravenous (IV) diuresis. Prospective, case control study of chronic HF patients presenting to emergency department (ED) with worsening congestion discharged to receive Furoscix 80 mg/10 ml 5-h subcutaneous infusion for ≤7 days. 30-day HF-related costs in Furoscix group derived from commercial claims database compared with matched historical patients hospitalized for
ISSN:1479-6678
1744-8298
DOI:10.2217/fca-2023-0071